Abnova Taiwan Corp
Abnova (Taiwan) Corporation manufactures and sells various recombinant proteins and antibodies. The company's products portfolio includes SARS-CoV/CoV-2 DNA, RNA, proteins/peptides, lysates/slides, Ab pairs/kits, Ab arrays, polyclinic antibody, beads/dyes, in situ hybridization products, systems, and automations. It also offers MaxPab, monoclonal, polyclonal, recombinant, conjugate, secondary/tag… Read more
Abnova Taiwan Corp (4133) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.003x
Based on the latest financial reports, Abnova Taiwan Corp (4133) has a cash flow conversion efficiency ratio of 0.003x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$3.16 Million) by net assets (NT$1.24 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Abnova Taiwan Corp - Cash Flow Conversion Efficiency Trend (2009–2024)
This chart illustrates how Abnova Taiwan Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Abnova Taiwan Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Abnova Taiwan Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Dong-A Hwa Sung Co.Ltd
KQ:041930
|
0.049x |
|
Sunfon Construction Co Ltd
TWO:5514
|
-0.056x |
|
M-POWER INFORMATION Co., LTD.
TWO:6874
|
0.148x |
|
Moller Y Perez
SN:MOLLER
|
-0.019x |
|
MEGA International Development Co Ltd
TWO:5529
|
-0.059x |
|
ONE GROUP HOSPIT.DL-0001
F:XZ9
|
N/A |
|
Sernova Biotherapeutics Inc
XETRA:PSH0
|
0.007x |
|
Engtex Group Bhd
KLSE:5056
|
0.090x |
Annual Cash Flow Conversion Efficiency for Abnova Taiwan Corp (2009–2024)
The table below shows the annual cash flow conversion efficiency of Abnova Taiwan Corp from 2009 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | NT$1.31 Billion | NT$50.85 Million | 0.039x | -34.46% |
| 2023-12-31 | NT$1.29 Billion | NT$76.22 Million | 0.059x | -42.17% |
| 2022-12-31 | NT$1.29 Billion | NT$132.37 Million | 0.102x | +33.67% |
| 2021-12-31 | NT$1.21 Billion | NT$92.88 Million | 0.077x | -11.85% |
| 2020-12-31 | NT$1.21 Billion | NT$105.30 Million | 0.087x | +39.14% |
| 2019-12-31 | NT$1.19 Billion | NT$74.51 Million | 0.062x | -13.99% |
| 2018-12-31 | NT$1.23 Billion | NT$89.17 Million | 0.073x | +31.77% |
| 2017-12-31 | NT$1.22 Billion | NT$67.53 Million | 0.055x | -9.84% |
| 2016-12-31 | NT$1.18 Billion | NT$71.94 Million | 0.061x | -2.83% |
| 2015-12-31 | NT$1.17 Billion | NT$73.43 Million | 0.063x | -17.82% |
| 2014-12-31 | NT$1.23 Billion | NT$94.18 Million | 0.077x | -14.21% |
| 2013-12-31 | NT$1.23 Billion | NT$109.78 Million | 0.089x | +44.31% |
| 2012-12-31 | NT$1.23 Billion | NT$76.02 Million | 0.062x | -41.44% |
| 2011-12-31 | NT$1.27 Billion | NT$134.22 Million | 0.106x | +17.26% |
| 2010-12-31 | NT$1.27 Billion | NT$114.40 Million | 0.090x | +71.09% |
| 2009-12-31 | NT$1.21 Billion | NT$63.72 Million | 0.053x | -- |